Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,387.17
1,413.51
1,275.77
1,132.55
938.03
813.08
602.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,387.17
1,413.51
1,275.77
1,132.55
938.03
813.08
602.99
Raw Material Cost
567.21
532.23
437.36
326.26
265.00
254.27
196.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
125.17
121.36
99.18
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.29
0.12
0.16
0.17
0.05
0.04
0.70
Selling and Distribution Expenses
532.51
577.52
585.68
580.40
458.75
392.65
281.79
Other Expenses
2.39
-2.66
-1.92
6.75
6.19
4.36
2.38
Total Expenditure (Excl Depreciation)
1,249.03
1,204.66
1,103.16
974.30
785.69
690.53
502.43
Operating Profit (PBDIT) excl Other Income
138.1
208.9
172.60000000000002
158.2
152.3
122.6
100.60000000000001
Other Income
48.30
37.55
32.91
29.15
15.00
7.97
5.48
Operating Profit (PBDIT)
252.83
302.64
248.90
219.19
194.11
153.87
128.30
Interest
0.29
0.12
0.16
0.17
0.05
0.04
0.70
Exceptional Items
0.00
-5.27
0.00
-2.15
0.09
0.01
-0.13
Gross Profit (PBDT)
819.96
881.28
838.41
806.28
673.03
558.82
406.85
Depreciation
72.12
62.32
49.02
34.28
29.67
26.19
23.35
Profit Before Tax
180.42
234.92
199.72
182.59
164.48
127.65
104.12
Tax
22.92
36.84
21.57
19.27
19.45
11.64
15.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
164.32
211.32
182.80
160.76
145.03
116.01
88.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
164.32
211.32
182.80
160.76
145.03
116.01
88.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-25.56
-18.28
-9.42
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
138.76
193.04
173.39
160.76
145.03
116.01
88.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
0.0
0.0
0.0
Reserves
1,803.41
1,723.51
1,596.61
1,479.47
663.05
553.17
458.25
Earnings per share (EPS)
1.25
1.61
1.39
1.22
1.1
0.88
0.67
Diluted Earnings per share
1.25
1.61
1.39
1.22
1.1
0.88
0.67
Operating Profit Margin (Excl OI)
9.55%
14.34%
13.09%
13.75%
15.93%
14.72%
16.49%
Gross Profit Margin
18.21%
21.03%
19.5%
19.15%
20.7%
18.92%
21.14%
PAT Margin
11.85%
14.95%
14.33%
14.19%
15.46%
14.27%
14.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -1.86% vs 10.79% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -28.08% vs 11.30% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -22.86% vs 22.73% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 200.00% vs -50.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Hunan Warrant Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,387.17
0
1,387.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,387.17
0
1,387.17
Raw Material Cost
567.21
0
567.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
125.17
0
125.17
Power Cost
0
0
0.00
Manufacturing Expenses
0.29
0
0.29
Selling and Distribution Expenses
532.51
0
532.51
Other Expenses
2.39
0.00
2.39
Total Expenditure (Excl Depreciation)
1,249.03
0
1,249.03
Operating Profit (PBDIT) excl Other Income
138.14
0.00
138.14
Other Income
48.30
0
48.30
Operating Profit (PBDIT)
252.83
0
252.83
Interest
0.29
0
0.29
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
819.96
0
819.96
Depreciation
72.12
0
72.12
Profit Before Tax
180.42
0
180.42
Tax
22.92
0
22.92
Provisions and contingencies
0
0
0.00
Profit After Tax
164.32
0
164.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
164.32
0
164.32
Share in Profit of Associates
0
0
0.00
Minority Interest
-25.56
0
-25.56
Other related items
0.00
0.00
0.00
Consolidated Net Profit
138.76
0
138.76
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,803.41
0
1,803.41
Earnings per share (EPS)
1.25
0
1.25
Diluted Earnings per share
1.25
0
1.25
Operating Profit Margin (Excl OI)
9.55%
0%
0.00
9.55%
Gross Profit Margin
18.21%
0%
0.00
18.21%
PAT Margin
11.85%
0%
0.00
11.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 138.72 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -1.86% vs 10.79% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 13.88 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -28.08% vs 11.30% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.45 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -22.86% vs 22.73% in Dec 2023
Annual - Interest
Interest 0.03 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 200.00% vs -50.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.55%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






